GPS Wealth Strategies Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $611K | Sell |
7,812
-1,686
| -18% | -$132K | 0.07% | 158 |
|
|
2025
Q1 | $688K | Sell |
9,498
-1,318
| -12% | -$95.5K | 0.09% | 138 |
|
|
2024
Q4 | $801K | Sell |
10,816
-2,230
| -17% | -$165K | 0.1% | 122 |
|
|
2024
Q3 | $861K | Sell |
13,046
-4,368
| -25% | -$288K | 0.11% | 126 |
|
|
2024
Q2 | $1.61M | Sell |
17,414
-556
| -3% | -$51.4K | 0.24% | 75 |
|
|
2024
Q1 | $1.72M | Sell |
17,970
-102
| -0.6% | -$9.75K | 0.28% | 74 |
|
|
2023
Q4 | $1.38M | Buy |
18,072
+336
| +2% | +$25.6K | 0.25% | 77 |
|
|
2023
Q3 | $1.23M | Buy |
17,736
+118
| +0.7% | +$8.18K | 0.24% | 81 |
|
|
2023
Q2 | $1.66M | Buy |
17,618
+70
| +0.4% | +$6.6K | 0.31% | 62 |
|
|
2023
Q1 | $1.45M | Buy |
17,548
+1,196
| +7% | +$98.9K | 0.3% | 63 |
|
|
2022
Q4 | $1.22M | Buy |
16,352
+67
| +0.4% | +$5K | 0.37% | 60 |
|
|
2022
Q3 | $1.35M | Buy |
16,285
+180
| +1% | +$14.9K | 0.34% | 55 |
|
|
2022
Q2 | $1.53M | Buy |
16,105
+223
| +1% | +$21.2K | 0.39% | 51 |
|
|
2022
Q1 | $1.87M | Buy |
15,882
+446
| +3% | +$52.5K | 0.42% | 42 |
|
|
2021
Q4 | $2M | Sell |
15,436
-324
| -2% | -$42K | 0.44% | 38 |
|
|
2021
Q3 | $1.78M | Buy |
15,760
+629
| +4% | +$71.2K | 0.44% | 40 |
|
|
2021
Q2 | $1.57M | Buy |
15,131
+408
| +3% | +$42.3K | 0.4% | 45 |
|
|
2021
Q1 | $1.23M | Buy |
14,723
+1,780
| +14% | +$149K | 0.36% | 45 |
|
|
2020
Q4 | $1.18M | Buy |
12,943
+67
| +0.5% | +$6.11K | 0.41% | 45 |
|
|
2020
Q3 | $1.03M | Buy |
+12,876
| New | +$1.03M | 0.41% | 44 |
|